Application Note: Predicting Outcomes Post-Transplant with ddPCR
5 December 2018
A high proportion of acute myeloid leukemia (AML) patients relapse following stem-cell transplant. Inferior outcome has been associated with pre-transplant measurable residual disease (MRD) in mulitple studies. This abstract reports the utilization of ddPCR as an MRD platform to track mutations in 33 AML patients.